Blood Plasma Market Strategic Insights 2021-2031
The Blood Plasma Market is expected to register a CAGR of 10% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Blood Plasma Market report delivers a comprehensive analysis categorized by component Type, Application, and End User. It includes a regional breakdown highlighting key markets and countries, providing a global perspective. Market evaluations are presented in US dollars (US$), offering insights into market dynamics, growth trends, and competitive landscapes across various segments. This information empowers stakeholders to recognize opportunities and make informed decisions in the evolving blood plasma industry.
Purpose of the ReportThe report Blood Plasma Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Blood Plasma Market Segmentation
Components- Albumin
- Coagulation Factors
- Immunoglobin
- Hyperimmune and Other Plasma Fractionation Products
- Oncology
- Rheumatology
- Neurology
- Transplant
- Immunology
- Pulmonology and Hematology
- Research Laboratories
- Hospitals and Clinics
- Academic Institutions
Strategic Insights
Blood Plasma Market Growth Drivers- Rise in incidence of chronic and rare diseases: The incidence of chronic and rare diseases such as haemophilia and immune deficiencies, a rising geriatric population, increased incidence of blood disorders, and blood consumption owing to diagnosed diseases are projected to fuel the global blood plasma market.
- Improved technical support: Improved technical support for plasma collection and processing from a regulatory standpoint and enhance availability of plasma for development of futuristic plasma products for various disease curing applications is driving the blood plasma market growth.
- Rising interest futuristic therapies: Moreover, rise in patient, physician and government interest in futuristic therapies such as immunotherapy and regenerative medicine is likely to push the market ahead. COVID-19 has played a significant role in recognising the need of blood plasma for therapeutics development, thus widening its applications, strengthening the confidence of various stakeholders in the same and increasing investments to establish these plasma collection centres.
- fractionation technologies: The most celebrated achievements in fractionation technologies are being reported to increase the yield from production of plasma-derived products. Such plasma products are moving away from being general medications to targeted and more personalised or customised medicines.
- strategic collaborations: Ongoing reports of collaborations between the plasma fractionators and the pharma companies point towards the intent to stay on the top of supply chain of human blood plasma.
- aggressive donor awareness: Promising results of the campaigns to create more aggressive donor awareness are driving up donor participation. ? The regulators are steadfast demanding the vital safety and quality standards from the companies that enable patients’ treatment with the best possible outcomes. The companies are passionately innovating their practices to meet and satisfy all these demands.
- Building plasma collection sites: Businesses have an opportunity to step in as well, since this massive need for plasma-derived therapies creates a niche for enterprises to invest in the building of plasma collection sites and in other areas where healthcare needs are increasing. Partnerships with health service providers and with pharmaceutical companies allow companies to leverage this capital and enable the development of new therapies, new products and even new lines of products.
- Service Differentiation: Furthermore, new fractionation technologies hold potential for greater value-adding or cost-effectiveness, as in higher degrees of plasma processing. Lastly, treatment development, especially for the treatment of chronic and rare diseases, can be a source of differentiation for clinics competing with each other. Public awareness and sponsorship can lead to improved donation rates, further enhancing supply, and more importantly, additional goodwill in the community.
- Targeted therapies using their patient-specific plasma: Along with the trend of personalized medicine, companies also can create targeted therapies using their patient-specific plasma. However, capitalisation in other markets might have a better position. It includes further growth into those emerging markets having increased prevalence of health spending. Moreover, increased safety rules with better product quality will assist gaining confidence and trust from end product customers, positioning the company as one of a leader in blood plasma market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Blood Plasma Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Blood Plasma Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to register a CAGR of 10% during 2023–2031
Continued growth is supported by a rising need for plasma-derived therapies for chronic diseases, aging populations and an improved regulatory landscape, all fuelled by the COVID-19 pandemic, with increased levels of investment in plasma collection centers and awareness of blood disorders.
Others include improvements in fractionation technologies and attempts at 'precision medicine'. Relations between plasma centres and pharmaceutical companies optimise supply chains, while marketing campaigns increase the number of donors. Moreover, regulatory requirements to promote safe plasma practices stimulated innovative plasma production practices.
Key market players are - CSL, Grifols, Shire, Octapharma, Kedrion, LFB, Biotest, Sanquin, China Biologic Products
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Blood Plasma Market - By Component
1.3.2 Blood Plasma Market - By Type of Plasma
1.3.3 Blood Plasma Market - By Application
1.3.4 Blood Plasma Market - By End User
1.3.5 Blood Plasma Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BLOOD PLASMA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BLOOD PLASMA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BLOOD PLASMA MARKET - GLOBAL MARKET ANALYSIS
6.1. BLOOD PLASMA - GLOBAL MARKET OVERVIEW
6.2. BLOOD PLASMA - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BLOOD PLASMA MARKET - REVENUE AND FORECASTS TO 2028 - COMPONENT
7.1. OVERVIEW
7.2. COMPONENT MARKET FORECASTS AND ANALYSIS
7.3. ALBUMIN
7.3.1. Overview
7.3.2. Albumin Market Forecast and Analysis
7.4. COAGULATION FACTORS
7.4.1. Overview
7.4.2. Coagulation factors Market Forecast and Analysis
7.5. IMMUNOGLOBULIN
7.5.1. Overview
7.5.2. Immunoglobulin Market Forecast and Analysis
7.6. HYPERIMMUNE GLOBULIN
7.6.1. Overview
7.6.2. Hyperimmune Globulin Market Forecast and Analysis
7.7. OTHER PLASMA FRACTIONATION PRODUCTS
7.7.1. Overview
7.7.2. Other Plasma Fractionation Products Market Forecast and Analysis
8. BLOOD PLASMA MARKET - REVENUE AND FORECASTS TO 2028 - TYPE OF PLASMA
8.1. OVERVIEW
8.2. TYPE OF PLASMA MARKET FORECASTS AND ANALYSIS
8.3. HUMAN PLASMA
8.3.1. Overview
8.3.2. Human Plasma Market Forecast and Analysis
8.4. DISEASE STATE PLASMA
8.4.1. Overview
8.4.2. Disease State Plasma Market Forecast and Analysis
8.5. SIMULATED BODY FLUID (SBF)
8.5.1. Overview
8.5.2. Simulated Body Fluid (SBF) Market Forecast and Analysis
9. BLOOD PLASMA MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ONCOLOGY
9.3.1. Overview
9.3.2. Oncology Market Forecast and Analysis
9.4. RHEUMATOLOGY
9.4.1. Overview
9.4.2. Rheumatology Market Forecast and Analysis
9.5. NEUROLOGY
9.5.1. Overview
9.5.2. Neurology Market Forecast and Analysis
9.6. TRANSPLANT
9.6.1. Overview
9.6.2. Transplant Market Forecast and Analysis
9.7. IMMUNOLOGY
9.7.1. Overview
9.7.2. Immunology Market Forecast and Analysis
9.8. PULMONOLOGY
9.8.1. Overview
9.8.2. Pulmonology Market Forecast and Analysis
9.9. HEMATOLOGY
9.9.1. Overview
9.9.2. Hematology Market Forecast and Analysis
10. BLOOD PLASMA MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. RESEARCH LABORATORIES
10.3.1. Overview
10.3.2. Research Laboratories Market Forecast and Analysis
10.4. HOSPITALS AND CLINICS
10.4.1. Overview
10.4.2. Hospitals and Clinics Market Forecast and Analysis
10.5. ACADEMIC INSTITUTIONS
10.5.1. Overview
10.5.2. Academic Institutions Market Forecast and Analysis
11. BLOOD PLASMA MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Blood Plasma Market Overview
11.1.2 North America Blood Plasma Market Forecasts and Analysis
11.1.3 North America Blood Plasma Market Forecasts and Analysis - By Component
11.1.4 North America Blood Plasma Market Forecasts and Analysis - By Type of Plasma
11.1.5 North America Blood Plasma Market Forecasts and Analysis - By Application
11.1.6 North America Blood Plasma Market Forecasts and Analysis - By End User
11.1.7 North America Blood Plasma Market Forecasts and Analysis - By Countries
11.1.7.1 United States Blood Plasma Market
11.1.7.1.1 United States Blood Plasma Market by Component
11.1.7.1.2 United States Blood Plasma Market by Type of Plasma
11.1.7.1.3 United States Blood Plasma Market by Application
11.1.7.1.4 United States Blood Plasma Market by End User
11.1.7.2 Canada Blood Plasma Market
11.1.7.2.1 Canada Blood Plasma Market by Component
11.1.7.2.2 Canada Blood Plasma Market by Type of Plasma
11.1.7.2.3 Canada Blood Plasma Market by Application
11.1.7.2.4 Canada Blood Plasma Market by End User
11.1.7.3 Mexico Blood Plasma Market
11.1.7.3.1 Mexico Blood Plasma Market by Component
11.1.7.3.2 Mexico Blood Plasma Market by Type of Plasma
11.1.7.3.3 Mexico Blood Plasma Market by Application
11.1.7.3.4 Mexico Blood Plasma Market by End User
11.2. EUROPE
11.2.1 Europe Blood Plasma Market Overview
11.2.2 Europe Blood Plasma Market Forecasts and Analysis
11.2.3 Europe Blood Plasma Market Forecasts and Analysis - By Component
11.2.4 Europe Blood Plasma Market Forecasts and Analysis - By Type of Plasma
11.2.5 Europe Blood Plasma Market Forecasts and Analysis - By Application
11.2.6 Europe Blood Plasma Market Forecasts and Analysis - By End User
11.2.7 Europe Blood Plasma Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Blood Plasma Market
11.2.7.1.1 Germany Blood Plasma Market by Component
11.2.7.1.2 Germany Blood Plasma Market by Type of Plasma
11.2.7.1.3 Germany Blood Plasma Market by Application
11.2.7.1.4 Germany Blood Plasma Market by End User
11.2.7.2 France Blood Plasma Market
11.2.7.2.1 France Blood Plasma Market by Component
11.2.7.2.2 France Blood Plasma Market by Type of Plasma
11.2.7.2.3 France Blood Plasma Market by Application
11.2.7.2.4 France Blood Plasma Market by End User
11.2.7.3 Italy Blood Plasma Market
11.2.7.3.1 Italy Blood Plasma Market by Component
11.2.7.3.2 Italy Blood Plasma Market by Type of Plasma
11.2.7.3.3 Italy Blood Plasma Market by Application
11.2.7.3.4 Italy Blood Plasma Market by End User
11.2.7.4 Spain Blood Plasma Market
11.2.7.4.1 Spain Blood Plasma Market by Component
11.2.7.4.2 Spain Blood Plasma Market by Type of Plasma
11.2.7.4.3 Spain Blood Plasma Market by Application
11.2.7.4.4 Spain Blood Plasma Market by End User
11.2.7.5 United Kingdom Blood Plasma Market
11.2.7.5.1 United Kingdom Blood Plasma Market by Component
11.2.7.5.2 United Kingdom Blood Plasma Market by Type of Plasma
11.2.7.5.3 United Kingdom Blood Plasma Market by Application
11.2.7.5.4 United Kingdom Blood Plasma Market by End User
11.2.7.6 Rest of Europe Blood Plasma Market
11.2.7.6.1 Rest of Europe Blood Plasma Market by Component
11.2.7.6.2 Rest of Europe Blood Plasma Market by Type of Plasma
11.2.7.6.3 Rest of Europe Blood Plasma Market by Application
11.2.7.6.4 Rest of Europe Blood Plasma Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Blood Plasma Market Overview
11.3.2 Asia-Pacific Blood Plasma Market Forecasts and Analysis
11.3.3 Asia-Pacific Blood Plasma Market Forecasts and Analysis - By Component
11.3.4 Asia-Pacific Blood Plasma Market Forecasts and Analysis - By Type of Plasma
11.3.5 Asia-Pacific Blood Plasma Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Blood Plasma Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Blood Plasma Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Blood Plasma Market
11.3.7.1.1 Australia Blood Plasma Market by Component
11.3.7.1.2 Australia Blood Plasma Market by Type of Plasma
11.3.7.1.3 Australia Blood Plasma Market by Application
11.3.7.1.4 Australia Blood Plasma Market by End User
11.3.7.2 China Blood Plasma Market
11.3.7.2.1 China Blood Plasma Market by Component
11.3.7.2.2 China Blood Plasma Market by Type of Plasma
11.3.7.2.3 China Blood Plasma Market by Application
11.3.7.2.4 China Blood Plasma Market by End User
11.3.7.3 India Blood Plasma Market
11.3.7.3.1 India Blood Plasma Market by Component
11.3.7.3.2 India Blood Plasma Market by Type of Plasma
11.3.7.3.3 India Blood Plasma Market by Application
11.3.7.3.4 India Blood Plasma Market by End User
11.3.7.4 Japan Blood Plasma Market
11.3.7.4.1 Japan Blood Plasma Market by Component
11.3.7.4.2 Japan Blood Plasma Market by Type of Plasma
11.3.7.4.3 Japan Blood Plasma Market by Application
11.3.7.4.4 Japan Blood Plasma Market by End User
11.3.7.5 South Korea Blood Plasma Market
11.3.7.5.1 South Korea Blood Plasma Market by Component
11.3.7.5.2 South Korea Blood Plasma Market by Type of Plasma
11.3.7.5.3 South Korea Blood Plasma Market by Application
11.3.7.5.4 South Korea Blood Plasma Market by End User
11.3.7.6 Rest of Asia-Pacific Blood Plasma Market
11.3.7.6.1 Rest of Asia-Pacific Blood Plasma Market by Component
11.3.7.6.2 Rest of Asia-Pacific Blood Plasma Market by Type of Plasma
11.3.7.6.3 Rest of Asia-Pacific Blood Plasma Market by Application
11.3.7.6.4 Rest of Asia-Pacific Blood Plasma Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Blood Plasma Market Overview
11.4.2 Middle East and Africa Blood Plasma Market Forecasts and Analysis
11.4.3 Middle East and Africa Blood Plasma Market Forecasts and Analysis - By Component
11.4.4 Middle East and Africa Blood Plasma Market Forecasts and Analysis - By Type of Plasma
11.4.5 Middle East and Africa Blood Plasma Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Blood Plasma Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Blood Plasma Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Blood Plasma Market
11.4.7.1.1 South Africa Blood Plasma Market by Component
11.4.7.1.2 South Africa Blood Plasma Market by Type of Plasma
11.4.7.1.3 South Africa Blood Plasma Market by Application
11.4.7.1.4 South Africa Blood Plasma Market by End User
11.4.7.2 Saudi Arabia Blood Plasma Market
11.4.7.2.1 Saudi Arabia Blood Plasma Market by Component
11.4.7.2.2 Saudi Arabia Blood Plasma Market by Type of Plasma
11.4.7.2.3 Saudi Arabia Blood Plasma Market by Application
11.4.7.2.4 Saudi Arabia Blood Plasma Market by End User
11.4.7.3 U.A.E Blood Plasma Market
11.4.7.3.1 U.A.E Blood Plasma Market by Component
11.4.7.3.2 U.A.E Blood Plasma Market by Type of Plasma
11.4.7.3.3 U.A.E Blood Plasma Market by Application
11.4.7.3.4 U.A.E Blood Plasma Market by End User
11.4.7.4 Rest of Middle East and Africa Blood Plasma Market
11.4.7.4.1 Rest of Middle East and Africa Blood Plasma Market by Component
11.4.7.4.2 Rest of Middle East and Africa Blood Plasma Market by Type of Plasma
11.4.7.4.3 Rest of Middle East and Africa Blood Plasma Market by Application
11.4.7.4.4 Rest of Middle East and Africa Blood Plasma Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Blood Plasma Market Overview
11.5.2 South and Central America Blood Plasma Market Forecasts and Analysis
11.5.3 South and Central America Blood Plasma Market Forecasts and Analysis - By Component
11.5.4 South and Central America Blood Plasma Market Forecasts and Analysis - By Type of Plasma
11.5.5 South and Central America Blood Plasma Market Forecasts and Analysis - By Application
11.5.6 South and Central America Blood Plasma Market Forecasts and Analysis - By End User
11.5.7 South and Central America Blood Plasma Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Blood Plasma Market
11.5.7.1.1 Brazil Blood Plasma Market by Component
11.5.7.1.2 Brazil Blood Plasma Market by Type of Plasma
11.5.7.1.3 Brazil Blood Plasma Market by Application
11.5.7.1.4 Brazil Blood Plasma Market by End User
11.5.7.2 Argentina Blood Plasma Market
11.5.7.2.1 Argentina Blood Plasma Market by Component
11.5.7.2.2 Argentina Blood Plasma Market by Type of Plasma
11.5.7.2.3 Argentina Blood Plasma Market by Application
11.5.7.2.4 Argentina Blood Plasma Market by End User
11.5.7.3 Rest of South and Central America Blood Plasma Market
11.5.7.3.1 Rest of South and Central America Blood Plasma Market by Component
11.5.7.3.2 Rest of South and Central America Blood Plasma Market by Type of Plasma
11.5.7.3.3 Rest of South and Central America Blood Plasma Market by Application
11.5.7.3.4 Rest of South and Central America Blood Plasma Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BLOOD PLASMA MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. BLOOD PLASMA MARKET, KEY COMPANY PROFILES
14.1. CSL
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. GRIFOLS
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. SHIRE
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. OCTAPHARMA
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. KEDRION
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. LFB CORP
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BIOTEST AG
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. SANQUIN
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. SK PLASMA CO., LTD.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
14.11. PENTRACOR GMBH
14.11.1. Key Facts
14.11.2. Business Description
14.11.3. Products and Services
14.11.4. Financial Overview
14.11.5. SWOT Analysis
14.11.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. CSL
2. Grifols
3. Shire
4. Octapharma
5. Kedrion
6. LFB
7. Biotest
8. Sanquin
9. China Biologic Products
10. Bio Products Laboratory
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For